Share this post on:

Name :
KIAA0087 antibody

Documents :
DataSheet Material Safety Data Sheets (MSDS)

Description :
KIAA0087 Rabbit Polyclonal antibody. Positive IHC detected in human colon cancer tissue, human brain tissue. Positive WB detected in fetal human brain tissue, SW 1990 cells. Observed molecular weight by Western-blot: ~40 kDa

Tested applications :
ELISA, WB, IHC

Species reactivity :
Human; other species not tested.

Alternative names :
KIAA0087 antibody

Immunogen :

Isotype :
Rabbit IgG

Preparation :
This antibody was obtained by immunization of KIAA0087 recombinant protein (Accession Number: BC128257). Purification method: Antigen affinity purified.

Clonality :
Polyclonal

Formulation :
PBS with 0.1% sodium azide and 50% glycerol pH 7.3.

Storage instructions :
Store at -20℃. DO NOT ALIQUOT

Applications :
Recommended Dilution: WB: 1:200-1:2000IHC: 1:20-1:200

Background :
This KIAA0087 antibody always gives 40 kDa in our detection.

References :

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Adintrevimab
TBK1 Antibody (YA662)
ERK1 Antibody: ERK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to ERK1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Gardos- Channel